ACST - アカスティ・ファ―マ （Acasti Pharma Inc.）ACSTのニュース
Acasti Pharma announces CEO transition 2023/04/04 12:38:51 Seeking Alpha
Late-stage specialty pharma company advancing drug candidates for rare and orphan diseases, Acasti Pharma (ACST) appoints Prashant Kohli as CEO, succeeding Jan D''Alvise
Acasti Pharma Announces Resignation of Jean-Marie Canan from Board 2023/03/30 12:35:07 Investing.com
https://www.investing.com/news/assorted/acasti-pharma-announces-resignation-of-jeanmarie-canan-from-board-432SI-3045146
Acasti Pharma Inc. Announces the Resignation of a Director 2023/03/30 12:30:00 PR Newswire
LAVAL, QC, March 30, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST) a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that Mr. Jean-Marie (John) Canan had tendered…
Acasti Pharma to Participate in Oppenheimer 33rd Annual Healthcare Conference 2023/03/08 14:00:00 PR Newswire
LAVAL, QC, March 8, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced Jan D''alvise, CEO, will…
Acasti Pharma Recognizes Rare Disease Day 2023/02/28 18:00:00 PR Newswire
LAVAL, QC, Feb. 28, 2023 /PRNewswire/ -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, recognizes and celebrates Rare Disease Day…
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript 2022/11/15 04:23:11 Seeking Alpha
Acasti Pharma Inc. (NASDAQ:NASDAQ:ACST) Q2 2023 Earnings Conference Call November 14, 2022 01:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Jan D''Alvise - President &…
Acasti Pharma Reports Q2 Loss of $0.11 By Investing.com 2022/11/14 12:31:11 Investing.com
Acasti Pharma Reports Q2 Loss of $0.11
Acasti Pharma GAAP EPS of -$0.11 (NASDAQ:ACST) 2022/11/14 12:15:29 Seeking Alpha
Acasti Pharma press release (ACST): Q3 GAAP EPS of -$0.11.The Company finished the second fiscal quarter ended September 30, 2022, with $34.9 million in cash, cash equivalents…
Acasti Pharma Reports Second Quarter 2023 Operational Results 2022/11/14 12:00:00 GlobeNewswire
Company to Host Conference Call Today at 1:00pm ET
Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022 2022/11/07 21:15:00 GlobeNewswire
Call to be held on Monday, November 14th at 1:00 PM Eastern Time Call to be held on Monday, November 14th at 1:00 PM Eastern Time
Acasti Pharma Inc. (ACST) Q2 2023 Earnings Call Transcript 2022/11/15 04:23:11 Seeking Alpha
Acasti Pharma Inc. (NASDAQ:NASDAQ:ACST) Q2 2023 Earnings Conference Call November 14, 2022 01:00 PM ET Company Participants Robert Blum - Lytham Partners, IR Jan D''Alvise - President &…
Acasti Pharma Reports Q2 Loss of $0.11 By Investing.com 2022/11/14 12:31:11 Investing.com
Acasti Pharma Reports Q2 Loss of $0.11
Acasti Pharma GAAP EPS of -$0.11 (NASDAQ:ACST) 2022/11/14 12:15:29 Seeking Alpha
Acasti Pharma press release (ACST): Q3 GAAP EPS of -$0.11.The Company finished the second fiscal quarter ended September 30, 2022, with $34.9 million in cash, cash equivalents…